Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $35.6600 (-2.73%) ($35.5100 - $35.6600) on Thu. Jul. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.94% (three month average) | RSI | 32 | Latest Price | $35.6600(-2.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.3% a day on average for past five trading days. | Weekly Trend | TGTX declines -3.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.47% in a week (0% probabilities). VIXM(-46%) VXX(-39%) UUP(-19%) UNG(-4%) TLT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.47% (StdDev 2.94%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $28.21(-20.89%) | Resistance Level | $37.69 | 5 Day Moving Average | $35.91(-0.7%) | 10 Day Moving Average | $36.68(-2.78%) | 20 Day Moving Average | $37.69(-5.39%) | To recent high | -19.9% | To recent low | 9.9% | Market Cap | $4.516b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |